Skip to main content
Have a personal or library account? Click to login
Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes Cover

Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes

Endocrine Regulations
Volume 55 (2021): Issue 3 (July 2021)
By:  and    
Open Access
|Sep 2021
Articles in this issue
DOI: https://doi.org/10.2478/enr-2021-0020 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 182 - 192
Published on: Sep 13, 2021
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
statins,
flaxseed lignan complex,
cinnamic acids,
3-hydroxy-3-methylglutaric acid,
3-hydroxy-3-methylglutaric acid coenzyme A reductase inhibition,
type 2 diabetes mellitus,
central obesity,
hyperglycemia,
hypertension,
dyslipidemia,
pro-thrombosis,
oxidation and inflammation
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2021 Douglas Edward Barre, Kazimiera Amelia Mizier-Barre, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 55 (2021): Issue 3 (July 2021)
Previous article